Search

Women who have reconstructive surgery after mastectomy and radiation for breast cancer are usually more satisfied with the results when their own tissue is used instead of implants.

… Thursday, December 8, 2016 Summary Women undergoing mastectomy for breast cancer have two main options for reconstructive surgery : artificial implants or flap surgery using their own tissue. A new study looked at these options in women who received radiation after mastectomy and found that those whose

A new drug for ovarian cancer, which was developed based on lab research at MSK, is transforming the possibilities for patients like Ellen Coopersmith.

… Thursday, September 11, 2025 VIDEO | 02:38 Watch How a Lab Discovery Sparked New Treatment for Rare Ovarian Cancer Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients meet the

The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the American Association for Thoracic Surgery and the Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, March 15, 2024 The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the  American Association for Thoracic Surgery and the  Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK). TSOG is a network of thoracic surgeons

The Peritoneal Surface Malignancies Consortium Group is a national, multidisciplinary collaboration of surgical and medical gastrointestinal oncology specialists from top cancer centers. The group recently published a series of updated consensus guidelines for the clinical management of peritoneal metastases related to a variety of gastrointestinal malignancies. In this Q&A with Dr. Michael Foote we discuss discuss the major updates for the management of colorectal cancer and appendiceal cancer peritoneal metastases and how the changes will improve patient outcomes and streamline patient care.

… Tuesday, December 23, 2025 A Q&A with  Michael Foote, MD , MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM Consortium Group) is a national, multidisciplinary collaboration of surgical

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, August 31, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Vinod Balachandran Awarded the 2023 FNIH Trailblazer Prize for Clinician-Scientists Vinod Balachandran, MD , hepatopancreatobiliary surgeon, was awarded the  2023 Trailblazer

The broad-spectrum antibiotic piperacillin-tazobactam used as perioperative prophylaxis significantly reduced surgical site infection (SSI) in patients undergoing open pancreatoduodenectomy (PD, or the Whipple procedure) compared with the standard-of-care cefoxitin, according to results from the first-ever registry-linked surgical clinical trial conducted in North America. The findings, published in JAMA on April 20, support using piperacillin-tazobactam as a standard of care for this patient population.

… Thursday, April 20, 2023 The broad-spectrum antibiotic piperacillin-tazobactam used as perioperative prophylaxis significantly reduced surgical site infection (SSI) in patients undergoing open pancreatoduodenectomy (PD, or the Whipple procedure) compared with the standard-of-care cefoxitin, according

Dr. Brown, whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation and cancer, was among 30 early career scientists nationwide selected for the 2025 class of scholars.

… Wednesday, October 1, 2025 Immunologist Chrysothemis Brown, MD, PhD , whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation, and cancer, was among 30 early-career scientists nationwide selected for the 2025

Learn about some of the most important advances in cancer treatment at MSK in 2025.

… Monday, December 15, 2025 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in a variety of cancer treatments in 2025 — including new approaches to immunotherapy, targeted therapy, and surgical imaging. Highlights this year also included a stem cell–based therapy for Parkinson

New research from Sloan Kettering Institute investigators pinpoints altered cell metabolism as a cause of B cell lymphoma.

… Monday, June 22, 2020 Summary Scientists at the Sloan Kettering Institute have found that increased activity of a normal metabolic enzyme can lead to cancer. The enzyme, SHMT2, is a driver of a large portion of B cell lymphomas and could be a potential drug target. Because of how aggressively they divide

Research from investigators at the Sloan Kettering Institute shows how a brain circuit controls mating behavior in fruit flies.

… Thursday, June 25, 2020 Summary Sloan Kettering Institute scientists have discovered how a genetic switch in the brain controls mating behavior in female fruit flies. The insights contribute to scientists’ understanding of fundamental neurobiological processes, including those that may go awry in disease